title: Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.
abstract: Blue nevi may display significant atypia or undergo malignant transformation. Morphologic diagnosis of this spectrum of lesions is notoriously difficult, and molecular tools are increasingly used to improve diagnostic accuracy. We studied copy number aberrations in a cohort of cellular blue nevi, atypical cellular blue nevi, and melanomas ex blue nevi using Affymetrix's OncoScan platform. Cases with sufficient DNA were analyzed for GNAQ, GNA11, and HRAS mutations. Copy number aberrations were detected in 0 of 5 (0%) cellular blue nevi, 3 of 12 (25%) atypical cellular blue nevi, and 6 of 9 (67%) melanomas ex blue nevi. None of the atypical cellular blue nevi displayed more than one aberration, whereas complex aberrations involving four or more regions were seen exclusively in melanomas ex blue nevi. Gains and losses of entire chromosomal arms were identified in four of five melanomas ex blue nevi with copy number aberrations. In particular, gains of 1q, 4p, 6p, and 8q, and losses of 1p and 4q were each found in at least two melanomas. Whole chromosome aberrations were also common, and represented the sole finding in one atypical cellular blue nevus. When seen in melanomas, however, whole chromosome aberrations were invariably accompanied by partial aberrations of other chromosomes. Three melanomas ex blue nevi harbored aberrations, which were absent or negligible in their precursor components, suggesting progression in tumor biology. Gene mutations involving GNAQ and GNA11 were each detected in two of eight melanomas ex blue nevi. In conclusion, copy number aberrations are more common and often complex in melanomas ex blue nevi compared with cellular and atypical cellular blue nevi. Identification of recurrent gains and losses of entire chromosomal arms in melanomas ex blue nevi suggests that development of new probes targeting these regions may improve detection and risk stratification of these lesions.
authors.affiliation: Department of Pathology, University of Michigan, Ann Arbor, MI, USA.|Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: May P
authors.initials: MP
authors.lastname: Chan
authors.affiliation: Department of Pathology, University of Michigan, Ann Arbor, MI, USA.|Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Aleodor A
authors.initials: AA
authors.lastname: Andea
authors.affiliation: Department of Pathology, University of Michigan, Ann Arbor, MI, USA.|Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Paul W
authors.initials: PW
authors.lastname: Harms
authors.affiliation: Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Alison B
authors.initials: AB
authors.lastname: Durham
authors.affiliation: Department of Pathology, University of Michigan, Ann Arbor, MI, USA.|Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Rajiv M
authors.initials: RM
authors.lastname: Patel
authors.affiliation: Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Min
authors.initials: M
authors.lastname: Wang
authors.affiliation: Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Patrick
authors.initials: P
authors.lastname: Robichaud
authors.affiliation: Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Gary J
authors.initials: GJ
authors.lastname: Fisher
authors.affiliation: Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Johnson
authors.affiliation: Department of Pathology, University of Michigan, Ann Arbor, MI, USA.|Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Douglas R
authors.initials: DR
authors.lastname: Fullen
mesh_terms: D000293:Adolescent; D000328:Adult; D000369:Aged, 80 and over; D002648:Child; D002869:Chromosome Aberrations; D004252:DNA Mutational Analysis; D005260:Female; D018628:Gene Dosage; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics* / Q000473:pathology*; D042282:Microdissection; D008875:Middle Aged; D018329:Nevus, Blue / Q000235:genetics* / Q000473:pathology*; D020411:Oligonucleotide Array Sequence Analysis; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology*; D055815:Young Adult